Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | EDNRB | P24530 | 1/20 | 0.36 |
| ▸ | EDNRA | P25101 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 2/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27859509 | 0.86 | LTA4H (0.37) | ALDH1A1ALOX15KCNN4MAPK1CYP3A4 | |
| SCHEMBL27691475 | 0.83 | ALDH1A1 (0.39) | ALDH1A1ALOX15KCNN4MAPK1CYP3A4 | |
| SCHEMBL27801514 | 0.82 | KCNN4 (0.40) | ALDH1A1ALOX15KCNN4MAPK1CYP3A4 | |
| SCHEMBL27662558 | 0.78 | MEN1 (0.45) | MAPK1CYP3A4HIF1ALMNASMN1; SMN2 | |
| SCHEMBL27766103 | 0.78 | KCNN4 (0.38) | ALDH1A1ALOX15KCNN4MAPK1CYP3A4 | |
| SCHEMBL11355373 | 0.77 | ALDH1A1 (0.41) | ALDH1A1ALOX15KCNN4MAPK1CYP3A4 | |
| SCHEMBL3365376 | 0.77 | POLB (0.41) | ALDH1A1ALOX15KCNN4MAPK1CYP3A4 | |
| SCHEMBL27473812 | 0.77 | SCN5A (0.41) | ALDH1A1KIF11LMNAMAPT | |
| SCHEMBL2350021 | 0.76 | KIF11 (0.56) | ALDH1A1ALOX15KCNN4MAPK1KIF11 | |
| SCHEMBL379267 | 0.76 | KCNN4 (0.43) | ALDH1A1ALOX15KCNN4MAPK1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101029022-B | Process for producing nitrogen-containing aromatic ring derivative | EISAI R&D MAN CO LTD | 2011-01-12 | — | — | CN | disclosed |
| CN-101029022-A | Process for producing nitrogen-containing aromatic ring derivative | EISAI R&D MAN CO LTD (JP) | 2007-09-05 | — | — | CN | disclosed |
| CN-101024627-A | Nitrogen-containing aromatic ring derivatives | EISAI R&D MAN CO LTD (JP) | 2007-08-29 | — | — | CN | disclosed |
| CN-1308310-C | Nitrogen-containing aromatic ring derivatives | EISAI CO LTD (JP) | 2007-04-04 | — | — | CN | disclosed |
| CN-1500086-A | Aminopiperidine derivatives | 霍夫曼-拉罗奇有限公司 | 2004-05-26 | — | — | CN | disclosed |
| US-6737429-B2 | TREATMENT OF HIV MEDIATED DISEASES. | HOFFMANN-LA ROCHE INC. | 2004-05-18 | — | — | US | disclosed |
| EP-1417202-A2 | AMINOPIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | F. HOFFMANN-LA ROCHE AG (CH) | 2004-05-12 | — | — | EP | disclosed |
| CN-1440385-A | Pyrrole derivatives for the treatment of AIDS | HOFFMANN LA ROCHE (CH) | 2003-09-03 | — | — | CN | disclosed |
| EP-1301481-A1 | PYRROLE DERIVATIVES FOR TREATING AIDS | F. HOFFMANN-LA ROCHE AG (CH) | 2003-04-16 | — | — | EP | disclosed |
| US-20030069276-A1 | Amino piperidine derivatives | F.HOFFMANN-LA ROCHE AG (CH) | 2003-04-10 | — | — | US | disclosed |
| WO-2002079186-A2 | AMINOPIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | F. HOFFMANN-LA ROCHE AG (CH) | 2002-10-10 | — | — | WO | disclosed |
| US-20020032221-A1 | Pyrrole derivatives | ROCHE PRODUCTS LIMITED (GB) | 2002-03-14 | — | — | US | disclosed |
| WO-2002002524-A1 | PYRROLE DERIVATIVES FOR TREATING AIDS | F. HOFFMANN-LA ROCHE AG (CH) | 2002-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069276-A1 | Amino piperidine derivatives | CCR5, CCR2, CXCR4 | ALDH1A1 1935/4885ALOX15 3235/4885KCNN4 4207/4885 |
| US-20020032221-A1 | Pyrrole derivatives | PYCR1, SARS1, MAVS | ALDH1A1 2902/4885ALOX15 2101/4885KCNN4 4860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.